Cargando…
Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells
On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose depriva...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402552/ https://www.ncbi.nlm.nih.gov/pubmed/36002449 http://dx.doi.org/10.1038/s41419-022-05177-x |
_version_ | 1784773201327292416 |
---|---|
author | Hyroššová, Petra Aragó, Marc Muñoz-Pinedo, Cristina Viñals, Francesc García-Rovés, Pablo M. Escolano, Carmen Méndez-Lucas, Andrés Perales, Jose C. |
author_facet | Hyroššová, Petra Aragó, Marc Muñoz-Pinedo, Cristina Viñals, Francesc García-Rovés, Pablo M. Escolano, Carmen Méndez-Lucas, Andrés Perales, Jose C. |
author_sort | Hyroššová, Petra |
collection | PubMed |
description | On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose deprivation promoted entosis in an MCF7 breast carcinoma model, as evaluated by direct inspection under the microscope, or revealed by a shift to apoptosis + necrosis in cells undergoing entosis treated with a Rho-GTPase kinase inhibitor (ROCKi). In this context, curbing protein glycosylation defects with N-acetyl-glucosamine partially rescued entosis, whereas limiting glycosylation in the presence of glucose with tunicamycin or NGI-1, but not with other unrelated ER-stress inducers such as thapsigargin or amino-acid limitation, stimulated entosis. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M; PCK2) is upregulated by glucose deprivation, thereby enhancing cell survival. Therefore, we presumed that PEPCK-M could play a role in this process by offsetting key metabolites into glycosyl moieties using alternative substrates. PEPCK-M inhibition using iPEPCK-2 promoted entosis in the absence of glucose, whereas its overexpression inhibited entosis. PEPCK-M inhibition had a direct role on total protein glycosylation as determined by Concanavalin A binding, and the specific ratio of fully glycosylated LAMP1 or E-cadherin. The content of metabolites, and the fluxes from (13)C-glutamine label into glycolytic intermediates up to glucose-6-phosphate, and ribose- and ribulose-5-phosphate, was dependent on PEPCK-M content as measured by GC/MS. All in all, we demonstrate for the first time that protein glycosylation defects precede and initiate the entosis process and implicates PEPCK-M in this survival program to dampen the consequences of glucose deprivation. These results have broad implications to our understanding of tumor metabolism and treatment strategies. |
format | Online Article Text |
id | pubmed-9402552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-94025522022-08-26 Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells Hyroššová, Petra Aragó, Marc Muñoz-Pinedo, Cristina Viñals, Francesc García-Rovés, Pablo M. Escolano, Carmen Méndez-Lucas, Andrés Perales, Jose C. Cell Death Dis Article On glucose restriction, epithelial cells can undergo entosis, a cell-in-cell cannibalistic process, to allow considerable withstanding to this metabolic stress. Thus, we hypothesized that reduced protein glycosylation might participate in the activation of this cell survival pathway. Glucose deprivation promoted entosis in an MCF7 breast carcinoma model, as evaluated by direct inspection under the microscope, or revealed by a shift to apoptosis + necrosis in cells undergoing entosis treated with a Rho-GTPase kinase inhibitor (ROCKi). In this context, curbing protein glycosylation defects with N-acetyl-glucosamine partially rescued entosis, whereas limiting glycosylation in the presence of glucose with tunicamycin or NGI-1, but not with other unrelated ER-stress inducers such as thapsigargin or amino-acid limitation, stimulated entosis. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M; PCK2) is upregulated by glucose deprivation, thereby enhancing cell survival. Therefore, we presumed that PEPCK-M could play a role in this process by offsetting key metabolites into glycosyl moieties using alternative substrates. PEPCK-M inhibition using iPEPCK-2 promoted entosis in the absence of glucose, whereas its overexpression inhibited entosis. PEPCK-M inhibition had a direct role on total protein glycosylation as determined by Concanavalin A binding, and the specific ratio of fully glycosylated LAMP1 or E-cadherin. The content of metabolites, and the fluxes from (13)C-glutamine label into glycolytic intermediates up to glucose-6-phosphate, and ribose- and ribulose-5-phosphate, was dependent on PEPCK-M content as measured by GC/MS. All in all, we demonstrate for the first time that protein glycosylation defects precede and initiate the entosis process and implicates PEPCK-M in this survival program to dampen the consequences of glucose deprivation. These results have broad implications to our understanding of tumor metabolism and treatment strategies. Nature Publishing Group UK 2022-08-24 /pmc/articles/PMC9402552/ /pubmed/36002449 http://dx.doi.org/10.1038/s41419-022-05177-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hyroššová, Petra Aragó, Marc Muñoz-Pinedo, Cristina Viñals, Francesc García-Rovés, Pablo M. Escolano, Carmen Méndez-Lucas, Andrés Perales, Jose C. Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title | Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title_full | Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title_fullStr | Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title_full_unstemmed | Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title_short | Glycosylation defects, offset by PEPCK-M, drive entosis in breast carcinoma cells |
title_sort | glycosylation defects, offset by pepck-m, drive entosis in breast carcinoma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402552/ https://www.ncbi.nlm.nih.gov/pubmed/36002449 http://dx.doi.org/10.1038/s41419-022-05177-x |
work_keys_str_mv | AT hyrossovapetra glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT aragomarc glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT munozpinedocristina glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT vinalsfrancesc glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT garciarovespablom glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT escolanocarmen glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT mendezlucasandres glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells AT peralesjosec glycosylationdefectsoffsetbypepckmdriveentosisinbreastcarcinomacells |